期刊
NUCLEIC ACIDS RESEARCH
卷 42, 期 10, 页码 6256-6269出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gku281
关键词
-
资金
- National Institute for Health Research Cambridge Biomedical Research Centre
- National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (ProMPT) [G0500966/75466]
- Cambridge Cancer Research Foundation, Cambridge
- University of Cambridge, Cambridge
- Cancer Research UK, Cambridge
- Hutchison Whampoa Limited
- Prostate Cancer UK
- Cancer Research UK Programme Grant [RG69651/SWAH.001]
- Cancer Research UK [22310] Funding Source: researchfish
- Medical Research Council [G0900871] Funding Source: researchfish
- National Institute for Health Research [CL-2012-14-003] Funding Source: researchfish
- MRC [G0900871] Funding Source: UKRI
In prostate cancer (PC), the androgen receptor (AR) is a key transcription factor at all disease stages, including the advanced stage of castrate-resistant prostate cancer (CRPC). In the present study, we show that GABP alpha, an ETS factor that is up-regulated in PC, is an AR-interacting transcription factor. Expression of GABP alpha enables PC cell lines to acquire some of the molecular and cellular characteristics of CRPC tissues as well as more aggressive growth phenotypes. GABP alpha has a transcriptional role that dissects the overlapping cistromes of the two most common ETS gene fusions in PC: overlapping significantly with ETV1 but not with ERG target genes. GABP alpha bound predominantly to gene promoters, regulated the expression of one-third of AR target genes and modulated sensitivity to AR antagonists in hormone responsive and castrate resistant PC models. This study supports a critical role for GABP alpha in CRPC and reveals potential targets for therapeutic intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据